---
schema_version: "secwatch.filing_event.v1"
accession: "0001299130-25-000152"
form_type: "8-K"
ticker: "PACB"
cik: "0001299130"
company_name: "PACIFIC BIOSCIENCES OF CALIFORNIA, INC."
filed_at: "2025-08-07T23:59:59+00:00"
generated_at: "2026-05-17T17:11:33.693553+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# PacBio Q2 revenue up 10.5% YoY to $39.8M; GAAP net loss narrows to $41.9M

## Summary
- GAAP net loss per share of $0.14 improved from $0.64 YoY; non-GAAP EPS -$0.13 vs -$0.20.
- Consumable revenue $18.9M (+11% YoY); service & other revenue $6.7M (+56% YoY).
- Shipped 15 Revio and 38 Vega systems; Revio annualized pull-through ~$219K/system.
- Cash, equivalents, and investments $314.7M, down from $509.8M a year earlier.
- Non-GAAP operating expenses cut to $58.1M from $71.0M YoY; CEO cites disciplined cost management.

## SEC filing metadata
- accession: 0001299130-25-000152
- form_type: 8-K
- ticker: PACB
- cik: 0001299130
- company_name: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- filed_at: 2025-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1299130/000129913025000152/0001299130-25-000152-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1299130/000129913025000152/pacb-20250807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001299130-25-000152
- JSON: https://secwatch.observer/filing/0001299130-25-000152.json
- Plain text: https://secwatch.observer/filing/0001299130-25-000152.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.